Venture Capital News: Axonics Modulation Technologies Inks $32.6M in Series A

Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Axonics Modulation Technologies Inks $32.6M in Series A

Back to Home

2014-03-25

IRVINE, CA, Developer of novel implantable neuromodulation technology, announced today that it has completed a $32.6 million in Series A.

>> Click here for more funding data on Axonics Modulation Technologies

>> To export Axonics Modulation Technologies funding data to PDF and Excel, click here

(c) by Massinvestor, Inc. For contact info, please check out our about page.

>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors